Fougera Report issue

Contributed to NME For profit Phase 2 Phase 3 Phase 4
Founded: Melville NY United States (1849)
Status: Acquired by Novartis (2012)

Organization Overview

First Clinical Trial
2004
NCT01137032
First Marketed Drug
1953
methylscopolamine bromide
First NDA Approval
1982
alclometasone (aclovate)
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

FOUGERA | Fougera Pharmaceuticals Inc. | FOUGERA PHARMS | FOUGERA PHARMS INC